BRGX · Bioregenx, Inc.
$0.01
At close · Aug 28
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern. As reflected in the accompanying financial statements, for the three months ended March 31, 2026, the Company incurred a net loss of $(26,415), generated cash from operations of $26,629 and had a stockholder’s deficit of $4,533,316 as of that date. At March 31, 2026, the Company had cash on hand in the amount of $45,806. In addition, notes payable of $522,500 are in default. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$7.77M
Shares
971.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W close$0.01–0.03
Avg vol 30d37K
Short int10K · 0.0% float · 1.0d
Short vol8%
DataJan 2020–Aug 2026
Filing10-Q · May 20
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 20, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−38%
below
Price vs 50-day avg
−13%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
13%
near low
Momentum
relative strength
1-month return
−10%
trailing
6-month return
−27%
trailing
YTD return
−38%
this year
Relative strength
−40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -84.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−21%
Y/Y
Gross margin
81%
expanding
EPS growth
+100%
Y/Y
Free cash flow
$29.9K
Balance sheet
$1.1M
net debt
Quant / Vol
risk profile
Volatility
468%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
11.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−38%
Bearish
Price vs 50-day avg
−13%
Bearish
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
13%
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -84.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 13%
Range high $0
vs 200-day avg -38%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRGX
this stock
Bioregenx, Inc.
|
$7.77M | -38.0% | -20.8% | — | 0.0% |
|
VEEV
Veeva Systems Inc
|
$44.80B | +28.0% | +28.1% | 45.3 | 3.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$13.02B | -24.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.56B | +55.9% | +28.2% | 35.4 | 4.5% |
|
TEM
Tempus AI, Inc.
|
$11.56B | +6.8% | +83.4% | — | 16.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BRGX | +33.3% | -10.1% | -26.6% | +6.7% | -38.0% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +32.9% | -13.1% | -40.0% | +3.7% | -50.8% |